The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
April 18th 2025
From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.
What We're Reading: ACA Repeal Misconception; ACA Enrollment Status; Zika Vaccine Trial
December 28th 2017Poll finds one-third of Americans believe the Affordable Care Act has been repealed; enrollees in Obamacare coverage largely come from states that voted for President Donald Trump; 2 trials find Zika vaccines are safe and effective.
Read More
Checkpoint Inhibitors Associated With Prolonged Survival in NSCLC
December 28th 2017Checkpoint inhibitors, compared with docetaxel, are associated with significantly prolonged overall survival in second and later lines of treatment for advanced non–small cell lung cancer, according to study findings published in JAMA Oncology.
Read More
Can Technology-Based Interventions Be Used to Improve Adherence Among Adolescents?
December 27th 2017Low medication adherence is a problem in healthcare, in general. However, adolescents with chronic health conditions also have low adherence, but they are at a critical age when they can create routines and health behaviors that optimize disease management as they become adults.
Read More
Dr Amy Abernethy Discusses Community Oncologists' Role in Modernizing Evidence Generation
December 27th 2017Community oncologists have a major role in accelerating treatment development and providing them to patients, said Amy Abernethy, MD, PhD, the chief medical officer, chief scientific officer, and senior vice president of oncology at Flatiron Health.
Watch
What We're Reading: TV Drug Ads; Kmart Drug Settlement; Evidence-Based Medicine
December 27th 2017In the last 4 years, the number of drug ads seen on TV has increased 65%; Kmart settled a prescription drug case over allegations it was being overpaid by the government; understanding the term "evidence-based" and how critics and supporters view it.
Read More